Efficacy of combined immunosuppression with or without eltrombopag in children with newly diagnosed aplastic anemia

被引:25
作者
Goronkova, Olga [1 ,13 ]
Novichkova, Galina [1 ]
Salimova, Tatiana [1 ]
Kalinina, Irina [1 ]
Baidildina, Dina [1 ]
Petrova, Ulyana [1 ]
Antonova, Kristina [1 ]
Sadovskaya, Maria [1 ]
Suntsova, Elena [1 ]
Evseev, Dmitry [1 ]
Matveev, Victor [1 ]
Venyov, Dmitry [1 ]
Khachatryan, Lili [1 ]
Litvinov, Dmitry [1 ]
Pshonkin, Alexey [1 ]
Ovsyannikova, Galina [1 ]
Kotskaya, Natalia [1 ]
Gobadze, Darina [1 ]
Olshanskaya, Yulia [1 ]
Popov, Alexander [1 ]
Raykina, Elena [1 ]
Mironenko, Olga [1 ]
Voronin, Kirill [1 ]
Purbueva, Bazarma [2 ]
Boichenko, Elmira [3 ]
Dinikina, Yulia [4 ]
Guseynova, Evgeniya [5 ]
Sherstnev, Dmitry [6 ]
Kalinina, Elena [7 ]
Mezentsev, Sergey [8 ]
Streneva, Olga [9 ]
Yudina, Natalia [10 ]
Plaksna, Olga [11 ]
Erega, Elena [12 ]
Maschan, Michael [1 ]
Maschan, Alexey [1 ]
机构
[1] Dmitry Rogachev Natl Med Res Ctr Pediat Hematol On, Moscow, Russia
[2] Pirogov Russian Clin Childrens Hosp, Moscow, Russia
[3] St Petersburg Childrens City Hosp 1, St Petersburg, Russia
[4] Almazov Natl Med Res Ctr, St Petersburg, Russia
[5] Krasnoyarsk Reg Clin Hosp, Krasnoyarsk, Russia
[6] Razumovsky Saratov State Med Univ, Shustov Univ Clin Hosp 3, Saratov, Russia
[7] Samara Reg Clin Childrens Hosp, Samara, Russia
[8] Perm Reg Clin Hosp, Perm, Russia
[9] Ekaterinburg Reg Clin Childrens Hosp, Ekaterinburg, Russia
[10] Voronezh Reg Clin Childrens Hosp 1, Voronezh, Russia
[11] Reg Clin Childrens Hosp, Nizhnii Novgorod, Russia
[12] Piotrovich Reg Clin Childrens Hosp, Khabarovsk, Russia
[13] Dmitry Rogachev Natl Med Res Ctr Pediat Hematol On, Dept Pediat Hematol & Oncol, Samory Mashela Str 1, Moscow 117997, Russia
关键词
PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; RABBIT ANTITHYMOCYTE GLOBULIN; THERAPY; CYCLOSPORINE; HEMATOPOIESIS; HORSE;
D O I
10.1182/bloodadvances.2021006716
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We compared the efficacy and safety of eltrombopag (ELTR) combined with immunosuppressive therapy (IST) and IST alone in treatment-naive children with severe (SAA) and very severe (vSAA) aplastic anemia. Ninety-eight pediatric patients were randomized to receive horse antithymocyte globulin (hATG) and cyclosporin A (CsA) with (n = 49) or without (n = 49) ELTR. The primary endpoint was the overall response rate (ORR) at 4 months. After 4 months, nonresponders were crossed over to the alternative group. In all patients, the ORR in ELTR + IST and IST groups was similar (65% vs 53%; P = .218); however, the complete response (CR) rate was significantly higher in the ELTR + IST group (31% vs 12%; P = .027). In severity subgroups, the ORR was 89% vs 57% (P = .028) in favor of IST + ELTR in SAA, but it did not differ in patients with vSAA (52% vs 50%; P = .902). At 6 months after the crossover, 61% of initial ELTR(-) patients achieved a response compared with 17% of initial ELTR(+) patients (P = .016). No significant difference in ELTR + IST and IST groups was observed in the 3-year overall survival (OS) (89% vs 91%; P = .673) or the 3-year event-free survival (EFS) (53% vs 41%; P = .326). There was no unexpected toxicity related to ELTR. Adding ELTR to standard IST was well tolerated and increased the CR rate. The greatest benefit from ELTR combined with IST was observed in patients with SAA but not in those with vSAA. The second course of IST resulted in a high ORR in initial ELTR(-) patients who added ELTR and had limited efficacy among patients who received ELTR upfront. This trial was registered at Clinicaltrials.gov as #NCT03413306.
引用
收藏
页码:953 / 962
页数:10
相关论文
共 30 条
[1]   Addition of eltrombopag to immunosuppressive therapy in patients with newly diagnosed aplastic anemia [J].
Assi, Rita ;
Garcia-Manero, Guillermo ;
Ravandi, Farhad ;
Borthakur, Gautam ;
Daver, Naval G. ;
Jabbour, Elias ;
Burger, Jan ;
Estrov, Zeev ;
Dinardo, Courtney D. ;
Alvarado, Yesid ;
Hendrickson, Stephany ;
Ferrajoli, Alessandra ;
Wierda, William ;
Cortes, Jorge ;
Kantarjian, Hagop M. ;
Kadia, Tapan M. .
CANCER, 2018, 124 (21) :4192-4201
[2]   How I treat acquired aplastic anemia [J].
Bacigalupo, Andrea .
BLOOD, 2017, 129 (11) :1428-1436
[3]   Multiple bilateral hip fractures in a patient with dyskeratosis congenita caused by a novel mutation in the PARN gene [J].
Belaya, Z. ;
Golounina, O. ;
Nikitin, A. ;
Tarbaeva, N. ;
Pigarova, E. ;
Mamedova, E. ;
Vorontsova, M. ;
Shafieva, I. ;
Demina, I. ;
Van Hul, W. .
OSTEOPOROSIS INTERNATIONAL, 2021, 32 (06) :1227-1231
[4]  
CAMITTA BM, 1988, LANCET, V1, P303
[5]   Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia [J].
de Latour, R. Peffault ;
Kulasekararaj, A. ;
Iacobelli, S. ;
Terwel, S. R. ;
Cook, R. ;
Griffin, M. ;
Halkes, C. J. M. ;
Recher, C. ;
Barraco, F. ;
Forcade, E. ;
Vallejo, J-C ;
Drexler, B. ;
Mear, J-B ;
Smith, A. E. ;
Angelucci, E. ;
Raymakers, R. A. P. ;
de Groot, M. R. ;
Daguindau, E. ;
Nur, E. ;
Barcellini, W. ;
Russell, N. H. ;
Terriou, L. ;
Iori, A-P ;
La Rocca, U. ;
Sureda, A. ;
Sanchez-Ortega, I ;
Xicoy, B. ;
Jarque, I ;
Cavenagh, J. ;
de Fontbrune, F. Sicre ;
Marotta, S. ;
Munir, T. ;
Tjon, J. M. L. ;
Tavitian, S. ;
Praire, A. ;
Clement, L. ;
Rabian, F. ;
Marano, L. ;
Hill, A. ;
Palmisani, E. ;
Muus, P. ;
Cacace, F. ;
Frieri, C. ;
Van Lint, M-T ;
Passweg, J. R. ;
Marsh, J. C. W. ;
Socie, G. ;
Mufti, G. J. ;
Dufour, C. ;
Risitano, A. M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (01) :11-23
[6]   Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug [J].
Desmond, Ronan ;
Townsley, Danielle M. ;
Dumitriu, Bogdan ;
Olnes, Matthew J. ;
Scheinberg, Phillip ;
Bevans, Margaret ;
Parikh, Ankur R. ;
Broder, Kinneret ;
Calvo, Katherine R. ;
Wu, Colin O. ;
Young, Neal S. ;
Dunbar, Cynthia E. .
BLOOD, 2014, 123 (12) :1818-1825
[7]   Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT [J].
Dufour, Carlo ;
Veys, Paul ;
Carraro, Elisa ;
Bhatnagar, Neha ;
Pillon, Marta ;
Wynn, Rob ;
Gibson, Brenda ;
Vora, Ajay J. ;
Steward, Colin G. ;
Ewins, Anna M. ;
Hough, Rachael E. ;
de la Fuente, Josu ;
Velangi, Mark ;
Amrolia, Persis J. ;
Skinner, Roderick ;
Bacigalupo, Andrea ;
Risitano, Antonio M. ;
Socie, Gerard ;
de Latour, Regis Peffault ;
Passweg, Jakob ;
Rovo, Alicia ;
Tichelli, Andre ;
Schrezenmeier, Hubert ;
Hochsmann, Britta ;
Bader, Peter ;
van Biezen, Anja ;
Aljurf, Mahmoud D. ;
Kulasekararaj, Austin ;
Marsh, Judith C. ;
Samarasinghe, Sujith .
BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 (04) :585-594
[8]   Outcome of aplastic anaemia in children. A study by the severe aplastic anaemia and paediatric disease working parties of the European group blood and bone marrow transplant [J].
Dufour, Carlo ;
Pillon, Marta ;
Socie, Gerard ;
Rovo, Alicia ;
Carraro, Elisa ;
Bacigalupo, Andrea ;
Oneto, Rosi ;
Passweg, Jakob ;
Risitano, Antonio ;
Tichelli, Andre ;
de Latour, Regis Peffault ;
Schrezenmeier, Hubert ;
Hocshmann, Britta ;
Peters, Christina ;
Kulasekararaj, Austin ;
Van Biezen, Anja ;
Samarasinghe, Sujith ;
Hussein, Ayad Ahmed ;
Ayas, Mouhab ;
Aljurf, Mahmoud ;
Marsh, Judith .
BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 (04) :565-573
[9]   Preclinical Activity of Eltrombopag (SB-497115), an Oral, Nonpeptide Thrombopoietin Receptor Agonist [J].
Erickson-Miller, Connie L. ;
Delorme, Evelyne ;
Tian, Shin-Shay ;
Hopson, Christopher B. ;
Landis, Amy J. ;
Valoret, Elizabeth I. ;
Sellers, Teresa S. ;
Rosen, Jon ;
Miller, Stephen G. ;
Luengo, Juan I. ;
Duffy, Kevin J. ;
Jenkins, Julian M. .
STEM CELLS, 2009, 27 (02) :424-430
[10]   Eltrombopag added to immunosuppression for children with treatment-naive severe aplastic anaemia [J].
Groarke, Emma M. ;
Patel, Bhavisha A. ;
Gutierrez-Rodrigues, Fernanda ;
Rios, Olga ;
Lotter, Jennifer ;
Baldoni, Daniela ;
St Pierre, Annie ;
Shalhoub, Ruba ;
Wu, Colin O. ;
Townsley, Danielle M. ;
Young, Neal S. .
BRITISH JOURNAL OF HAEMATOLOGY, 2021, 192 (03) :605-614